Literature DB >> 19233767

Mitral valve replacement and Hunter syndrome: case report.

Theophani Antoniou1, G Kirvassilis, L Tsourelis, C Ieromonachos, D Zarkalis, P Alivizatos.   

Abstract

We report a rare case of mitral valve stenosis secondary to Hunter syndrome, mucopolysaccharoidosis (MPS) type II in a 33-year-old man. Anatomical abnormalities in patients with MPS present anesthetic and surgical challenges during cardiac surgery. Management of this particular patient was complicated by excessive oral secretions and atrial fibrillation. With a detailed preoperative assessment and planning for airway management, this patient successfully underwent mitral valve replacement and had an uncomplicated hospital course. After 6 months of follow-up, the patient was still in stable condition.

Entities:  

Mesh:

Year:  2009        PMID: 19233767     DOI: 10.1532/HSF98.20081108

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  4 in total

Review 1.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

Review 2.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04

3.  Double Valve Replacement in a Patient With Hunter Syndrome.

Authors:  Suresh Keshavamurthy; Andra Duncan; Akshay Kumar; Carlos Trombetta; Rene Rodriguez; Carmela Tan; Eric Roselli
Journal:  Cureus       Date:  2022-09-08

4.  Massive accumulation of glycosaminoglycans in the aortic valve of a patient with Hunter syndrome during enzyme replacement therapy.

Authors:  Yohei Sato; Masako Fujiwara; Hiroshi Kobayashi; Hiroyuki Ida
Journal:  Pediatr Cardiol       Date:  2013-02-13       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.